PuraStat as secondary therapy for hemostasis in Mallory−Weiss syndrome with oral antithrombotic medication
2024

Using PuraStat for Bleeding in Mallory-Weiss Syndrome

publication Evidence: low

Author Information

Author(s): Higashino Makoto, Murakami Hidehiro, Hirata Tetsu, Miyaoka Hiroaki

Primary Institution: Saiseikai Matsuyama Hospital

Hypothesis

Can PuraStat be effective for achieving hemostasis in Mallory-Weiss syndrome when other methods fail?

Conclusion

PuraStat can achieve complete hemostasis in Mallory-Weiss syndrome when traditional methods are insufficient.

Supporting Evidence

  • PuraStat has been used successfully in other types of gastrointestinal bleeding.
  • The patient had a large laceration that did not respond to clipping.
  • PuraStat was applied after initial treatment failed and achieved hemostasis.

Takeaway

If someone is bleeding in their stomach because of vomiting, a special gel called PuraStat can help stop the bleeding when other methods don't work.

Methodology

The patient was treated with endoscopy and PuraStat was applied after initial clipping failed to stop the bleeding.

Limitations

This is a single case report, and further studies are needed to confirm the efficacy of PuraStat in Mallory-Weiss syndrome.

Participant Demographics

The patient was a 67-year-old man with a history of coronary artery disease and was on antithrombotic medication.

Digital Object Identifier (DOI)

10.1002/deo2.70033

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication